Press Release

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

NeoGenomics Announces Board Appointments

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients